Our analysis of data on 1,500 US companies and 150 elections around the world between 2007 and 2022 identified three ...

Cambridge has enacted one of the most aggressive pro-housing zoning measures undertaken by a U.S. city in recent years: It ...

The plan, passed by the Cambridge City Council Monday night, makes the city the first in Massachusetts to eliminate ...

"Depending on who you are, this might sound scary or exciting," a city councilor said. "In reality, I think it's reasonable." ...

The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...

In his next chief executive gig after securing the $14 billion acquisition of Karuna Therapeutics Inc., Bill Meury has now locked in another big biotech deal.

Councilor Burhan Azeem argues the measure was a much-needed effort to allow for the development of more multi-family housing in the city.

Having already acquired UK-based Cambridge Antibody Technology in 2006, AstraZeneca merged these two companies to create a dedicated global biologics organisation known as MedImmune. Bestseller ...

It’s not too late, however, for Harvard to change its course, especially during the current community benefits negotiation ...

For Cambridge-based Artios ... The poster child of the DDR concept is AstraZeneca's top-selling PARP inhibitor Lynparza (olaparib), and some of Artios senior management – including chief ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 19,029.63 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...

Video of Our world-leading researchers are exploring how AI can benefit society. A 13th-century fresco, identified by a Cambridge historian in Ferrara, puts Islamic art at the heart of medieval ...